Board of Directors

The McGill University and Génome Québec Innovation Centre is governed by a Board of Directors with current membership from McGill University, Génome Québec, Genome Canada and the University of Oxford.


Dr. Cindy Bell
Executive Vice-President, Corporate Development, Genome Canada

Prof. Sir John Bell
Regius Professor of Medicine, University of Oxford

Prof. David Eidelman
Dean, Faculty of Medicine & Vice-Principal of Health Affairs

Prof. Rose Goldstein (Chair)
Vice-Principal of Research & International Relations, McGill University

Prof. Philippe Gros
Vice Dean, Life Sciences, Faculty of Medicine, McGill University

Prof. Mark Lathrop
Scientific Director, McGill University and Génome Québec Innovation Centre & Professor, Department of Human Genetics, McGill University

Mr. Marc Lepage
CEO, Génome Québec